Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 9/20 | 0.68 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.68 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.68 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | TLR2 | O60603 | 4/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.52 |
| ▸ | PRKCG | P05129 | 1/20 | 0.52 |
| ▸ | PRKCB | P05771 | 1/20 | 0.52 |
| ▸ | PRKCA | P17252 | 1/20 | 0.52 |
| ▸ | PRKCH | P24723 | 1/20 | 0.52 |
| ▸ | PRKCI | P41743 | 1/20 | 0.52 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.52 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.52 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.52 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.52 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.52 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.50 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7183039 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL30510651 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL30910033 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL30510614 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL4294185 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL8636551 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL4204833 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL303128 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL4879843 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL4204708 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114929844-A | Nitrate esters of ethers of glycerol and ethanol as cetane improvers in diesel fuels and process for producing the same | 巴西石油公司 | 2022-08-19 | — | — | CN | claimed |
| US-12582963-B2 | Separation matrix and method of separation | CYTIVA BIOPROCESS R&D AB (SE) | 2026-03-24 | — | — | US | disclosed |
| EP-4643993-A2 | CHROMATOGRAPHY MEDIA AND METHODS FOR PRODUCING THEM | Cytiva BioProcess R&D AB (SE) | 2025-11-05 | — | — | EP | disclosed |
| EP-3737494-B1 | CHROMATOGRAPHY MEDIA AND METHODS FOR PRODUCING THEM | CYTIVA BIOPROCESS R & D AB (SE) | 2025-09-10 | — | — | EP | disclosed |
| US-12397283-B1 | Chromatography media and methods for producing them | CYTIVA BIOPROCESS R&D AB (SE) | 2025-08-26 | — | — | US | disclosed |
| US-20250256263-A1 | Chromatography Media and Methods for Producing Them | CYTIVA BIOPROCESS R&D AB (SE) | 2025-08-14 | — | — | US | disclosed |
| US-20250153140-A1 | A FUNCTIONALISED CHROMATOGRAPHY MEDIUM LACKING SURFACE EXTENDER | CYTIVA BIOPROCESS R&D AB (SE) | 2025-05-15 | — | — | US | disclosed |
| EP-4486501-A1 | A FUNCTIONALISED CHROMATOGRAPHY MEDIUM LACKING SURFACE EXTENDER | Cytiva BioProcess R&D AB (SE) | 2025-01-08 | — | — | EP | disclosed |
| EP-4142930-B1 | SEPARATION MATRIX AND METHOD OF SEPARATION | PURIDIFY LTD (GB) | 2024-05-08 | — | — | EP | disclosed |
| CN-117945864-A | Method for synthesizing alkyl glyceryl ether by glycerin etherification | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-6387952-B1 | ALKOXYLATED ACYL GLYCEROL | ARCO CHEMICAL TECHNOLOGY L.P. | 2002-05-14 | — | — | US | disclosed |
| WO-2002024195-A1 | METHOD OF TREATING GASTROINTESTINAL DISORDERS, PARTICULARLY COLITIS | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 2002-03-28 | — | — | WO | disclosed |
| US-5641534-A | NON-DIGESTIBLE SYNTHETIC FAT MIMETICS; LOW CALORIE FOODS | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1997-06-24 | — | — | US | disclosed |
| US-5603978-A | TRIGLYCERIDES HAVING AT LEAST TWO PROPYLENE OXIDE GROUPS AND AT LEAST ONE UNSATURATED FATTY ACID ACYL MOIETY; RESISTANT TO DIGESTION AND HYDROLYSIS | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1997-02-18 | — | — | US | disclosed |
| EP-0325010-B1 | NON-DIGESTIBLE FAT SUBSTITUTES OF LOW-CALORIC VALUE | ARCO Chemical Technology, L.P. (US) | 1993-03-24 | — | — | EP | disclosed |
| EP-0254547-B1 | NON-DIGESTIBLE FAT SUBSTITUTES OF LOW-CALORIC VALUE | ARCO Chemical Technology, L.P. (US) | 1993-02-17 | — | — | EP | disclosed |
| US-4861613-A | Non-digestible fat substitutes of low-caloric value | ARCO CHEMICAL TECHNOLOGY, INC. (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0325010-A1 | Non-digestible fat substitutes of low-caloric value | ARCO Chemical Technology, L.P. (US) | 1989-07-26 | — | — | EP | disclosed |
| EP-0254547-A2 | Non-digestible fat substitutes of low-caloric value | ARCO Chemical Technology, L.P. (US) | 1988-01-27 | — | — | EP | disclosed |
| US-3993741-A | SELENIUM AND TELLURIUM COMPOUNDS; RADIOACTIVE MATERIALS | U.S. PHILIPS CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582963-B2 | Separation matrix and method of separation | EPCAM, PA2G4, MAG | LPAR1 841/4885LPAR3 1774/4885LPAR2 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.